title: Time-of-day differences in dopamine clearance in the rat medial prefrontal cortex and nucleus accumbens.
abstract: Circadian rhythms influence cocaine-seeking behavior in rats, and this behavior may be mediated by variability in the rate of extracellular dopamine clearance across the day:night cycle. We used rotating disk electrode voltammetry to examine dopamine clearance and inhibition of clearance by cocaine in the rat medial prefrontal cortex (mPFC) and nucleus accumbens (NAc). Rats were housed under light:dark conditions (LD, 12 h:12 h) or in constant darkness (DD), the latter given just prior to the day of sacrifice. Tissue was collected at 4-h intervals under LD and DD conditions. Under LD, dopamine clearance in both brain regions was greatest at 4h after lights on. Under DD, there was a blunted but still rhythmic pattern of dopamine clearance across the 24-h cycle. Cocaine-induced inhibition of dopamine clearance in the mPFC was not different across the day:night cycle in rats under LD. Paradoxically, under DD, dopamine clearance in the mPFC was enhanced by cocaine at ZT16, 4 h into the subjective night, and only minimally inhibited at other times. In the NAc, cocaine inhibition of dopamine clearance was lowest at ZT4 under LD, and did not vary under DD. We conclude that dopamine clearance varies both in a diurnal and possibly in a circadian manner in the mPFC, and in a diurnal manner in the NAc. These results indicate that light itself may be used to manipulate molecules implicated in drug addiction.
authors.affiliation: Program in Neuroscience, Washington State University, Pullman, Washington 99164, USA.
authors.forename: Evan P
authors.initials: EP
authors.lastname: Sleipness
authors.forename: Heiko T
authors.initials: HT
authors.lastname: Jansen
authors.forename: James O
authors.initials: JO
authors.lastname: Schenk
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Sorg
mesh_terms: D000204:Activity Cycles / Q000502:physiology*; D000818:Animals; D002940:Circadian Rhythm / Q000187:drug effects / Q000502:physiology; D003042:Cocaine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects / Q000502:physiology; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism*; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D003042:Cocaine; D004298:Dopamine
references.citation: Neuropeptides. 2003 Feb;37(1):57-65
references.pmid: 12637037
references.citation: Neuroendocrinology. 1996 Nov;64(5):337-48
references.pmid: 8930934
references.citation: Neuropsychopharmacology. 1996 May;14(5):325-37
references.pmid: 8703301
references.citation: Prog Drug Res. 2002;59:111-31
references.pmid: 12458965
references.citation: Braz J Med Biol Res. 1997 May;30(5):637-40
references.pmid: 9283632
references.citation: Neurosci Lett. 2003 Jul 31;346(1-2):37-40
references.pmid: 12850542
references.citation: Eur J Neurosci. 2003 Jan;17(2):221-8
references.pmid: 12542658
references.citation: Am J Physiol. 1992 Nov;263(5 Pt 2):R1110-4
references.pmid: 1443229
references.citation: Psychopharmacology (Berl). 2008 Jan;195(4):527-36
references.pmid: 17891383
references.citation: Brain Res. 1981 Oct 26;223(1):205-9
references.pmid: 7284805
references.citation: EMBO Rep. 2007 Apr;8(4):366-71
references.pmid: 17347670
references.citation: Biochem Pharmacol. 2001 Oct 1;62(7):929-32
references.pmid: 11543728
references.citation: Brain Res. 2007 Jan 19;1129(1):34-42
references.pmid: 17156761
references.citation: Psychopharmacology (Berl). 2003 Jul;168(1-2):170-176
references.pmid: 12845419
references.citation: J Neurosci. 2002 Apr 1;22(7):2916-25
references.pmid: 11923456
references.citation: Chronobiol Int. 1998 Sep;15(5):395-423
references.pmid: 9787933
references.citation: Experientia. 1974 Nov 15;30(11):1240-1
references.pmid: 4474089
references.citation: J Neurosci. 2002 Jan 15;22(2):389-95
references.pmid: 11784783
references.citation: BMC Neurosci. 2005 May 02;6:31
references.pmid: 15865626
references.citation: Neuroscience. 2003;119(2):497-505
references.pmid: 12770563
references.citation: Fed Proc. 1983 Aug;42(11):2783-9
references.pmid: 6135628
references.citation: J Biol Rhythms. 2004 Oct;19(5):400-13
references.pmid: 15534320
references.citation: Brain Res. 2005 Dec 14;1065(1-2):132-7
references.pmid: 16309631
references.citation: J Biol Rhythms. 2004 Oct;19(5):361-73
references.pmid: 15534317
references.citation: Neuroscience. 1997 Feb;76(3):737-47
references.pmid: 9135047
references.citation: Physiol Behav. 2005 Oct 15;86(3):347-55
references.pmid: 16126238
references.citation: Mol Cell Endocrinol. 1991 Aug;79(1-3):C153-8
references.pmid: 1936532
references.citation: Physiol Res. 2004;53 Suppl 1:S167-76
references.pmid: 15119947
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):9026-30
references.pmid: 12084940
references.citation: J Neurosci. 1995 May;15(5 Pt 2):4102-8
references.pmid: 7751968
references.citation: J Biol Chem. 1994 Mar 11;269(10):7124-30
references.pmid: 8125921
references.citation: Chronobiol Int. 1995 Apr;12(2):87-99
references.pmid: 8653803
references.citation: Psychopharmacology (Berl). 2005 Jan;177(3):315-23
references.pmid: 15309375
references.citation: J Pharmacol Exp Ther. 1995 Jun;273(3):1245-56
references.pmid: 7791097
references.citation: J Neurosci. 2001 Nov 1;21(21):8655-63
references.pmid: 11606653
references.citation: J Pharmacol Exp Ther. 1997 Jun;281(3):1401-7
references.pmid: 9190876
references.citation: Physiol Behav. 2007 Aug 15;91(5):523-30
references.pmid: 17573077
references.citation: J Biol Rhythms. 2001 Aug;16(4):302-11
references.pmid: 11506376
references.citation: Folia Psychiatr Neurol Jpn. 1980;34(4):481-92
references.pmid: 7196369
references.citation: Synapse. 1998 Nov;30(3):334-7
references.pmid: 9776137
references.citation: Brain Res. 1972 Jul 13;42(1):201-6
references.pmid: 5047187
references.citation: Neuroscience. 2006 Jul 7;140(3):753-7
references.pmid: 16678973
references.citation: Nature. 2002 Aug 29;418(6901):935-41
references.pmid: 12198538
references.citation: J Pineal Res. 2004 Apr;36(3):177-85
references.pmid: 15009508
references.citation: Neuroscience. 2000;100(4):741-8
references.pmid: 11036208
references.citation: Neuropsychopharmacology. 2006 Jul;31(7):1452-61
references.pmid: 16205775
references.citation: J Neurochem. 2001 Oct;79(1):130-42
references.pmid: 11595765
references.citation: Science. 1987 Sep 4;237(4819):1219-23
references.pmid: 2820058
references.citation: J Biol Chem. 2003 Jun 13;278(24):22168-74
references.pmid: 12682063
references.citation: J Biol Rhythms. 2005 Oct;20(5):430-40
references.pmid: 16267382
references.citation: Neuropsychopharmacology. 2003 Dec;28(12):2117-23
references.pmid: 12865893
references.citation: Brain Res. 1984 Oct 8;311(1):157-60
references.pmid: 6488037
references.citation: J Neurosci. 2001 Jan 1;21(1):35-44
references.pmid: 11150317
references.citation: Behav Neurosci. 1994 Jun;108(3):624-35
references.pmid: 7917055
references.citation: Gene. 1997 Aug 11;195(1):11-8
references.pmid: 9300814
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9377-81
references.pmid: 15967985
references.citation: Pharmacol Biochem Behav. 2004 Sep;79(1):37-42
references.pmid: 15388282
references.citation: Eur J Hum Genet. 2005 Oct;13(10):1101-3
references.pmid: 16094306
references.citation: J Pharmacol Exp Ther. 2000 Jul;294(1):239-47
references.pmid: 10871318
references.citation: Biochem Pharmacol. 1992 May 28;43(10):2189-99
references.pmid: 1599505
references.citation: J Neurochem. 1993 Aug;61(2):637-47
references.pmid: 8336146
references.citation: Brain Res Mol Brain Res. 1998 Jan;53(1-2):277-84
references.pmid: 9473694
references.citation: Mol Pharmacol. 1994 Feb;45(2):312-6
references.pmid: 7906856
references.citation: Arch Gen Psychiatry. 2006 Mar;63(3):324-31
references.pmid: 16520439
references.citation: Am J Psychiatry. 2005 Aug;162(8):1403-13
references.pmid: 16055761
references.citation: Annu Rev Physiol. 2001;63:647-76
references.pmid: 11181971
references.citation: Trends Pharmacol Sci. 1993 Feb;14(2):43-9
references.pmid: 8480373
references.citation: J Neurosci. 2002 Jan 1;22(1):350-6
references.pmid: 11756518
references.citation: J Comp Neurol. 2001 Oct 15;439(2):140-50
references.pmid: 11596044
references.citation: J Biol Chem. 1999 Dec 10;274(50):35794-801
references.pmid: 10585462